Driving the New Wave
of the Life Science Industry
2025
11
- Designated by the MFDS as an official Clinical Trial Education Provider
10
- JNPMEDI Partners : Established the Next-Generation Open Innovation Venture Investment Fund in partnership with TBT Partners
- JNPMEDI Partners : Signed MOU with University of Basel Innovation Office for global business cooperation
09
- Establishment of JNPMEDI Seoul Office
- Awarded the Minister of SMEs and Startups Commendation at the ‘2025 Incheon Startup Vitalization Awards’
08
- Signed MOU with Naver for global expansion in the digital healthcare sector
- Secured strategic investments from Naver and TBT
06
- Signed MOU with Open Research for joint research on AI-based medical information intelligence
- Signed MOU with MCRA to support domestic medical device companies entering the US market, and held a strategic workshop with MCRA and IQVIA
05
- Selected as a technical advisor for the 2025 Fund of Funds First-Round Regular Investment Project – Rookie League
04
- Launched the SDTM data conversion solution ‘Maven Converter’
- Signed MOU with Dongguk University to foster talent in the bio-healthcare sector
03
- Selected as AWS Managed Service Provider (MSP)
- Signed MOU with Kangnam University for talent development and startup support
- Designated as KHIDI investment support partner institution
02
- Signed an employment contract with a para-athlete
- Signed an MSA with Samjin Pharmaceutical to enhance clinical competitiveness through tailored IP strategies and management of legal requirements
01
- Selected as a supplier for the consulting sector of the SME Innovation Voucher Support Program
- Launched 'Maven TMF', the digital clinical trial document management solution
2024
12
- Obtained Family-Friendly Company Certification
- Signed an MOU with Hallym University and Chuncheon Sacred Heart Hospital
- Signed an MOU with MICROT for FDA 510(k) Approval of A-Stream
- Signed an MOU with Foundation for Medical Innovation for Clinical Approvals and Investment in Pharmaceuticals and Medical Devices
- Signed an MOU with BS Research to Accelerate Clinical Research using Bio-compatible Surface Modification Technology and Global Expansion
- Signed an MOU with Kyung Hee University College of Pharmacy
11
- Signed an MOU with Wonju Medical Device Techno Valley (WMIT) to advance Gangwon's medical device industry
10
- Signed an MOU with Research Institute for Dementia(RID) to develope AI-based clinical solutions
08
- Launched 'Maven Coder Express,' a generative AI-based medical coder
- Signed an MOU with Medirama to launch full-cycle service for oncology drug development
- Signed an MOU with Kangwon National University’s Industry-Academic Cooperation Foundation to activate the bio-innovation startup ecosystem and advance the global bio industry
07
- Launched 'FDA Expert Solution,' a comprehensive FDA regulatory consulting service
- Signed an MOU with The University of Utah Asia Campus to promote the South Korea-U.S. pharmaceutical and biotech industry
- Launched 'Maven VDR,' a Virtual Data Room tailored to the pharmaceutical and biotech industry
05
- First open recruitment for the GBP Clinical Operations field
- Signed an MOU with Korea University College of Pharmacy for education and research collaboration
- Signed an MOU with NEXTBIOMEDICAL for strengthening global competitiveness and technological collaboration
- Signed an MOU with CMAX Clinical Research (AU) for clinical trial business expansion
04
- Launched 'Maven Builder,' a Clinical Database Design Solution
- Signed an MOU with Chung-Ang University College of Pharmacy and Graduate School for industry-academia collaboration and talent development
- Established JNPMEDI Partners for an investment support program for innovative biotech and medical device companies
02
- Signed an MOU with SOLUM Healthcare for development and commercialization of sensor-based rapid cancer diagnosis solution
- Signed an MOU with Korea Innovation Medicine Consortium (KIMCo) for development of a global new drug R&D platform
2023
12
- Signed an MOU with Avance Clinical (AU)
- Launched 'Maven eRecruitment', an Online Clinical Trial Participant Recruitment Platform
11
- Signed an MOU with Yonsei University College of Pharmacy for research collaboration
09
- Selected for the Scale-up TIPS by Ministry of SMEs and Startups
07
- Signed an MOU with Kangbuk Samsung Hospital for establishing Smart Clinical Trial Center
05
- Launched 'Maven Safety,' a Pharmaceutical Safety Management Solution
04
- Obtained ISO/IEC 27701 Certification
02
- Obtained CDISC Platinum Membership
2022
12
- Secured Series A funding, including from Singapore's sovereign wealth fund
- Signed an MOU with Korea University Medical Center for clinical trial digitization
- Signed an MOU with ProSciento (U.S.A.) for solution expansion and service enhancement
11
- Signed contract with LSK Global PS for the use of 'Maven Docs'
- Implemented the enterprise analytics platform SAS Viya into 'Maven CDMS'
10
- Applied 'Maven DCT Suite' to Welt's Digital Insomnia Therapy
09
- Signed an MOU with Phantomics for collaborative development of a medical data platform and medical imaging AI software
08
- Signed an MOU with Mediaiplus for the activation of a global clinical trial data platform
04
- Selected for the TIPS by the Ministry of SMEs and Startups
- Signed an MOU with Mediplexus for solution expansion and service enhancement
- Obtained ISO 27701/27799 Certification
03
- Launched 'Maven Docs,' a Clinical Trial Document Management Solution
01
- Enrolled in DTRA for the first in Korea
- Approved of Maven CDMS WHODrug B3/C3 for the first in Korea
2021
12
- Signed an MOU with SCL Healthcare for Maven-Central Lab integration services
- Secured 2 billion KRW in seed investment, including from Kakao Ventures
11
- Signed an MOU with LSK Global PS for advancement of a medical data platform
10
- Signed an MOU with Alchera for integration of AI image recognition technology and a medical data platform
04
- Launched, 'Maven CDMS,' Clinical Data Management System
- Signed an MOU with CHA Bundang Medical Center's Global Clinical Trials Center for new drug research and development
2020
07
- Founded JNPMEDI Inc.